In 2023, the mortality rate from pancreas malignant neoplasms among women in Brazil stood at 6.3 deaths per one hundred thousand women. From 2024 to 2028, forecasted data shows a steady increase in the mortality rate from 6.5 to 7.3, indicating a year-on-year increase of approximately 3.08% from 2024 to 2025, and a constant increase pattern is observed in subsequent years. The compound annual growth rate (CAGR) for this period is around 2.91%.
Future trends to watch for include advancements in early detection and treatment options, which could potentially slow down or reverse the upward trend in mortality rates. Improvements in healthcare access and public health initiatives focusing on risk factor reduction will be essential factors to monitor as these could significantly impact future mortality rates from pancreatic cancer in women in Brazil.
